XML 105 R92.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2000
Stock options | Minimum        
Stock-Based Compensation        
Vesting period 3 years      
Stock options | Maximum        
Stock-Based Compensation        
Vesting period 5 years      
The 2000 Plan        
Stock-Based Compensation        
Plan expiration term       10 years
Bruker Corporation Stock Plan        
Stock-Based Compensation        
Common stock authorized for issuance (in shares) 8,000,000      
Bruker Corporation Stock Plan | Minimum        
Stock-Based Compensation        
Vesting period 3 years      
Bruker Corporation Stock Plan | Maximum        
Stock-Based Compensation        
Vesting period 5 years      
Bruker Corporation Stock Plan | Stock options        
Stock options, Shares Subject to Options        
Outstanding at the beginning of the period (in shares) 4,810,588      
Granted (in shares) 1,107,477      
Exercised (in shares) (926,042)      
Forfeited (in shares) (354,744)      
Outstanding at the end of the period (in shares) 4,637,279 4,810,588    
Exercisable at the end of the period (in shares) 2,355,197      
Exercisable and expected to vest at the end of the period (in shares) 4,504,918      
Stock options, Weighted Average Option Price        
Outstanding at the beginning of the period (in dollars per share) $ 15.24      
Granted (in dollars per share) 19.81      
Exercised (in dollars per share) 11.81      
Forfeited (in dollars per share) 19.17      
Outstanding at the end of the period (in dollars per share) 16.72 $ 15.24    
Exercisable at the end of the period (in dollars per share) 14.08      
Exercisable and expected to vest at the end of the period (in dollars per share) $ 16.64      
Stock options, Weighted Average Remaining Contractual Term        
Outstanding at the end of the period 6 years 6 months      
Exercisable at the end of the period 4 years 8 months 12 days      
Exercisable and expected to vest at the end of the period 6 years 6 months      
Stock options, Aggregate Intrinsic Value        
Outstanding at the end of the period (in dollars) $ 35.0      
Exercisable at the end of the period (in dollars) 24.0      
Exercisable and expected to vest at the end of the period (in dollars) $ 34.4      
Fair value of the Company's common stock price (in dollars per share) $ 24.27      
Weighted average fair values of options granted (in dollars per share) $ 7.82 $ 10.81 $ 10.37  
Intrinsic value of options exercised $ 8.2 $ 10.0 $ 8.1  
Additional share-based compensation disclosures        
Unrecognized pre-tax stock-based compensation expense $ 16.7      
Weighted average remaining service period 2 years 2 months 12 days      
Bruker Corporation Stock Plan | Restricted stock        
Restricted stock, Number of Shares        
Outstanding at the beginning of the period (in shares) 309,725      
Granted (in shares) 135,677      
Vested (in shares) (56,395)      
Forfeited (in shares) (145,857)      
Outstanding at the end of the period (in shares) 243,150 309,725    
Restricted stock, Weighted Average Grant Date Fair Value        
Outstanding at the beginning of the period (in dollars per share) $ 17.20      
Granted (in dollars per share) 19.83      
Vested (in dollars per share) 17.02      
Forfeited (in dollars per share) 17.42      
Outstanding at the end of the period (in dollars per share) $ 18.58 $ 17.20    
Additional share-based compensation disclosures        
Total fair value of shares vested $ 1.0 $ 3.0 $ 1.4  
Unrecognized pre-tax stock-based compensation expense $ 3.9      
Weighted average remaining service period 2 years 9 months 18 days      
Bruker Corporation Stock Plan | Restricted stock | Minimum        
Stock-Based Compensation        
Period of service restrictions 4 years      
Bruker Corporation Stock Plan | Restricted stock | Maximum        
Stock-Based Compensation        
Period of service restrictions 5 years